Literature DB >> 7658074

The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis.

I R Friedland1, M M Paris, S Hickey, S Shelton, K Olsen, J C Paton, G H McCracken.   

Abstract

The aim of this study was to determine the role of pneumolysin, an intracellular toxin of Streptococcus pneumoniae, in the pathogenesis of pneumococcal meningitis. Recombinant pneumolysin (1 microgram), when injected intracisternally into rabbits, resulted in a brisk inflammatory response. However, a pneumolysin-deficient strain of S. pneumoniae caused meningeal inflammation in rabbits indistinguishable from that induced by the parent pneumolysin-producing strain. Furthermore, similar enhancement of meningeal inflammation occurred after ampicillin therapy in animals infected with either the parent strain or the pneumolysin-deficient mutant. These results suggest that although pneumolysin can stimulate the inflammatory cascade in the central nervous system, it is not necessary for the pathogenesis of meningeal inflammation nor does it play a role in postantibiotic enhancement of meningeal inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658074     DOI: 10.1093/infdis/172.3.805

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin.

Authors:  A G Allen; S Bolitho; H Lindsay; S Khan; C Bryant; P Norton; P Ward; J Leigh; J Morgan; H Riches; S Eastty; D Maskell
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis.

Authors:  Anja Reiss; Johann S Braun; Katja Jäger; Dorette Freyer; Gregor Laube; Christoph Bührer; Ursula Felderhoff-Müser; Christine Stadelmann; Victor Nizet; Joerg R Weber
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

3.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Streptococcus pneumoniae-induced inhibition of rat ependymal cilia is attenuated by antipneumolysin antibody.

Authors:  Robert A Hirst; Bashir J Mohammed; Timothy J Mitchell; Peter W Andrew; Christopher O'Callaghan
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Pneumolysin causes neuronal cell death through mitochondrial damage.

Authors:  Johann S Braun; Olaf Hoffmann; Miriam Schickhaus; Dorette Freyer; Emilie Dagand; Daniela Bermpohl; Tim J Mitchell; Ingo Bechmann; Joerg R Weber
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

Review 6.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

7.  Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages.

Authors:  M Segura; J Stankova; M Gottschalk
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 8.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

9.  Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae.

Authors:  G Zysk; B K Schneider-Wald; J H Hwang; L Bejo; K S Kim; T J Mitchell; R Hakenbeck; H P Heinz
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.

Authors:  Esther Calbo; Montserrat Alsina; Mónica Rodríguez-Carballeira; Josep Lite; Javier Garau
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.